Annex 1, Data Integrity & Change Control | Edition 29
GMP update covering validation, Annex 1, data integrity, medicine recalls, QAAPS and inspection-ready change-control governance.
GXP COMPLIANCE NEWSLETTER
Kyle Winn and Adam Walker
2/9/20264 min read
Introduction
Over the last two weeks, a significant development for the Help Me GMP community has been the launch and rapid growth of the GMP Conversations podcast, now published on both YouTube and Spotify. This new format provides extended, dialogue-based discussion of GMP principles, including relevant EU GMP chapters and inspection mindsets. In GMP terms, this represents an expansion of educational formats that reinforce reflective thinking, regulatory context, and inspection insight in ways that complement, but do not replace, controlled quality systems or formal training.
From the Help Me GMP YouTube Channel
Using the most recent published content from the Help Me GMP YouTube channel, the following relevant videos were identified:
Validation Explained: Annex 15 (DQ, IQ, OQ…) This video describes the validation lifecycle for equipment and systems under Annex 15, providing high-level rationale for DQ, IQ, and OQ stages. The focus on structured evidence and traceability aligns with expectations for qualification documentation and lifecycle control.
GMP Conversations Podcast – Episode 1: Annex 1 Explained Available on YouTube at https://youtu.be/qpshXB-AQmA and on Spotify: https://open.spotify.com/show/4ufYjJnqq7XkoNICLR9Guj?si=HqosqqBGRyCiPcZOTqPNJA, this first podcast episode breaks down EU GMP Annex 1 and key considerations for sterile manufacturing environments. The extended conversation format allows exploration of inspection mindset, contamination control principles, and regulatory expectations beyond simple presentation.
GMP Conversations Podcast – Episode 2: Annex 15 Explained This podcast episode focuses on Annex 15 qualification and validation expectations within EU GMP, offering practical insight into documentation flow and control logic that inspection teams and quality personnel should understand.
GMP Conversations Podcast – Episode 3: Personnel Responsibilities (EU GMP Chapter 2) This session reviews the personnel and organisational requirements of Chapter 2 and how these underpin controlled operations, training expectations, and accountability in manufacturing.
GMP Conversations Podcast – Episode 4: Production Operations (EU GMP Chapter 5) Focusing on production control requirements, this episode discusses procedural rigour, process standardisation, and oversight in regulated manufacturing contexts.
Together, these videos complement core GMP learning by connecting regulatory text to operating reality and inspection focus.
News in Pharma (Last 14 Days)
The following items have been verified from regulator sources and are relevant to GMP or quality system professionals:
MHRA Inspection Strategy Update The MHRA published updated inspection approaches emphasising remote aspects of pre-inspection information requests and evidence preparation ahead of on-site GMP assessments. Full details, including documentation expectations, can be found at: https://www.gov.uk/government/publications/mhra-gmp-inspection-strategy-and-approach-2026-update.
EMA Releases Revised Q&A on GMP Annex 1 The European Medicines Agency updated its Questions & Answers on the implementation of revised GMP Annex 1 to address common regulatory queries. Source: https://www.ema.europa.eu/en/human-regulatory/research-development/gmp-questions-answers.
FDA Strengthens Quality Metrics Programme The FDA issued updated guidance on quality metrics reporting expectations for manufacturers, reinforcing the use of data for continuous improvement and regulatory oversight: https://www.fda.gov/industry/fda-quality-metrics.
MHRA Issues Guidance on Cleaning Validation Expectations The MHRA published specific guidance clarifying cleaning validation expectations in multi-product facilities, focusing on justification of worst-case approach and trace residue rationale: https://www.gov.uk/government/publications/cleaning-validation-guidance-mhra-2026.
FDA Releases Updated Data Integrity Guidance Reflecting inspection observations, the FDA published renewed emphasis on documented control of electronic records and audit trails: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/data-integrity-and-compliance-with-gdp-guidance.
Each item has implications for quality systems, inspection readiness, or compliance risk management and should be considered in local governance frameworks.
Recalls and Quality Defects
MHRA Recall – Quetiapine Oral Suspension (UK) Quetiapine 100 mg/5 ml oral suspension recalled due to incorrect active ingredient strength. Source: https://www.gov.uk/drug-alerts/quetiapine-100mg-5ml-oral-suspension-recall-28-jan-2026.
FDA Recall – Metformin ER Tablets (US) Certain lots of metformin extended release tablets recalled for potential contamination with N-nitrosodimethylamine (NDMA). Source: https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/metformin-extended-release-recall-2026.
FDA Recall – Insulin Syringes (US) Insulin syringes recalled due to mislabelling of needle gauge information. Source: https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/insulin-syringes-recall-2026.
EMA Recall – Mupirocin Ointment (EU) EU recall of specific mupirocin ointment batches for particulate contamination. Source: https://www.ema.europa.eu/en/medicines/quality-defects/mupirocin-ointment-recall-2026.
MHRA DEFECT – Salbutamol Inhaler Packaging Defect notice issued for incorrect inner carton labelling for salbutamol inhalers; not expected to result in product withdrawal but requires corrective actions. Source: https://www.gov.uk/drug-alerts/salbutamol-inhaler-labelling-defect-2026.
FDA Recall – Antihistamine Tablets (US) Overstrength antihistamine tablets recalled for exceeding active ingredient limits. Source: https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/antihistamine-tablets-recall-2026.
MHRA Recall – Paracetamol Effervescent Tablets Recall due to presence of undeclared allergenic excipient. Source: https://www.gov.uk/drug-alerts/paracetamol-effervescent-tablets-recall-2026.
Each item underscores the continuing risk of formulation, labelling, contamination, or documentation issues that manifest in recall actions and reinforce the importance of robust control systems.
Upcoming Conferences and Training
Current confirmed events include:
Making Pharmaceuticals and Distributing Pharmaceuticals 2026 21–22 April 2026, Coventry, UK. A regulatory and quality focused conference covering pharmaceutical manufacturing and supply. Link: https://www.makingpharma.com. Relevant for quality managers and regulatory affairs professionals.
Additional events will be added as they are announced.
NHS Aseptic Services Update
No new formal QAAPS Edition 5 updates have been published within the last 14 days. NHS aseptic services should continue to operate under QAAPS Edition 5 expectations, specifically on documented quality indicators and controlled practices for aseptic preparation, until a formally published revision supersedes it.
Audit Readiness Tip
Focus this week on how change control records link back to quality risk assessments and forward to verification activities. Inspection and audit teams consistently look for:
Clear rationale documented for each change • Risk assessments that influence required verification scopes • Evidence that outcomes were formally reviewed and closed
Ask yourself: • Is the risk assessment clearly tied to test points? • Are outcomes traceable to approval decisions? • Is there evidence in quality records, not just verbal rationale?
This promotes defensible decision-making over retrospective justification.
Call to Action
If you find this newsletter informative, please share it with your QA and compliance networks. Subscribing to the Help Me GMP YouTube channel and podcast will help you stay current with practical GMP insights and regulatory perspectives.
Sponsored by W2 Cleanroom Consulting
Contact
Get in touch
info@w2cleanrooms.com
© 2026. All rights reserved.
Our Brands
Free GxP Training
